RecruitingNot ApplicableNCT06841692

Diuretic Testing in Chronic Kidney Disease


Sponsor

Erasmus Medical Center

Enrollment

86 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to predict the progression of chronic kidney disease by diuretic testing in patients with chronic kidney disease. The main questions it aims to answer are: Does a worse result of a diuretic test predict the progression of chronic kidney disease? If there is a comparison group: Researchers will compare the diuretic test in patients with chronic kidney disease to healthy participants to see if the results are different in a healthy kidney. Participants will undergo diuretic testing. This involves the administration of bumetanide and hydrochlorothiazide with subsequent blood and urine collections.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing the response to water pills (diuretics) in people with moderate chronic kidney disease (CKD) compared to people with healthy kidneys. The goal is to better understand how the kidneys handle diuretics when they are not functioning at full capacity, which could guide better treatment decisions. **You may be eligible if...** - You have CKD stage G3 (kidney function at 30–59% of normal), confirmed at your last check-up - OR you are a healthy volunteer with kidney function normal for your age **You may NOT be eligible if...** - You have a known allergy or intolerance to diuretics - You are currently receiving chemotherapy for cancer - You have had a kidney transplant - You take calcineurin inhibitors or immunosuppressants for kidney disease - Your potassium levels are too high or too low - Your life expectancy is less than 12 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDiuretic Testing

The administration of hydrochlorothiazide and bumetanide is used to stimulate and assess tubular function.


Locations(1)

Erasmus MC

Rotterdam, South Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06841692


Related Trials